Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $111,615 | 3 | 90.5% |
| Acquisitions | $7,990 | 1 | 6.5% |
| Consulting Fee | $3,669 | 2 | 3.0% |
| Food and Beverage | $82.68 | 2 | 0.1% |
| Unspecified | $0 | 3 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Anika Therapeutics, Inc. | $119,604 | 4 | $0 (2021) |
| DePuy Synthes Products, Inc. | $3,669 | 2 | $0 (2022) |
| Arthrosurface Incorporated | $45.12 | 4 | $0 (2019) |
| Ethicon US, LLC | $37.56 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $675.00 | 1 | DePuy Synthes Products, Inc. ($675.00) |
| 2021 | $7,990 | 1 | Anika Therapeutics, Inc. ($7,990) |
| 2020 | $114,609 | 4 | Anika Therapeutics, Inc. ($111,615) |
| 2019 | $0 | 1 | Arthrosurface Incorporated |
| 2018 | $82.68 | 3 | Arthrosurface Incorporated ($45.12) |
| 2017 | $0 | 1 | Arthrosurface Incorporated |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2022 | DePuy Synthes Products, Inc. | RIGIDLOOP (Device) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Sports Surgical | ||||||
| 07/09/2021 | Anika Therapeutics, Inc. | — | Acquisitions | Cash or cash equivalent | $7,989.86 | General |
| 12/22/2020 | DePuy Synthes Products, Inc. | RIGIDLOOP (Device) | Consulting Fee | Cash or cash equivalent | $2,994.00 | General |
| Category: Sports Surgical | ||||||
| 10/27/2020 | Anika Therapeutics, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $4,017.25 | General |
| 05/11/2020 | Anika Therapeutics, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $356.41 | General |
| 02/03/2020 | Anika Therapeutics, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $107,240.88 | General |
| 2019 | Arthrosurface Incorporated | — | — | — | $0.00 | Ownership |
| 11/20/2018 | Arthrosurface Incorporated | HemiCAP Shoulder (Device) | Food and Beverage | In-kind items and services | $45.12 | General |
| Category: Musculoskeletal | ||||||
| 06/26/2018 | Ethicon US, LLC | DERMABOND Portfolio (Device), STRATAFIX | Food and Beverage | In-kind items and services | $37.56 | General |
| Category: Wound Closure | ||||||
| 2018 | Arthrosurface Incorporated | — | — | — | $0.00 | Ownership |
| 2017 | Arthrosurface Incorporated | — | — | — | $0.00 | Ownership |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 643 | 2,327 | $206,605 | $44,056 |
| 2022 | 10 | 861 | 10,122 | $272,113 | $68,925 |
| 2021 | 16 | 1,052 | 12,858 | $292,072 | $91,080 |
| 2020 | 11 | 777 | 2,181 | $211,911 | $48,351 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 201 | $45,426 | $12,259 | 27.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 122 | 211 | $60,712 | $10,845 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 83 | $27,473 | $7,731 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $27,000 | $7,002 | 25.9% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 87 | 94 | $13,356 | $2,967 | 22.2% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 44 | 48 | $6,480 | $1,341 | 20.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 117 | 1,616 | $24,240 | $1,266 | 5.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 14 | $1,918 | $644.00 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 157 | 252 | $53,496 | $16,495 | 30.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 147 | 238 | $65,720 | $12,606 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 125 | $39,125 | $11,561 | 29.5% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2022 | 12 | 7,393 | $20,331 | $10,528 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $31,338 | $8,077 | 25.8% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 101 | 120 | $15,705 | $3,711 | 23.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 74 | 83 | $10,365 | $2,291 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $7,044 | $1,506 | 21.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 139 | 1,800 | $27,000 | $1,501 | 5.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,989 | $648.51 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 192 | 306 | $52,632 | $21,242 | 40.4% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2021 | 17 | 9,744 | $25,788 | $16,860 | 65.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 154 | 257 | $70,970 | $14,387 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 109 | $27,904 | $10,560 | 37.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $34,017 | $10,424 | 30.6% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 122 | 151 | $14,592 | $4,890 | 33.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 87 | 112 | $11,200 | $2,991 | 26.7% |
About Dr. David Moss, M.D
Dr. David Moss, M.D is a Sports Medicine healthcare provider based in Johnston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891743068.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Moss, M.D has received a total of $123,356 in payments from pharmaceutical and medical device companies, with $675.00 received in 2022. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($111,615).
As a Medicare-enrolled provider, Moss has provided services to 3,333 Medicare beneficiaries, totaling 27,488 services with total Medicare billing of $252,411. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Johnston, RI
- Active Since 05/04/2006
- Last Updated 04/08/2009
- Taxonomy Code 207XX0005X
- Entity Type Individual
- NPI Number 1891743068
Products in Payments
- RIGIDLOOP (Device) $3,669
- HemiCAP Shoulder (Device) $45.12
- DERMABOND Portfolio (Device) $37.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.